Generic drug of the therapeutic class: Dermatology
active ingredients: Betamethasone, Salicylic acid
laboratory: Msd France
30 g tube
Corticosensitive dermatoses with keratotic or squamous component:
1. Preferred indications where local corticosteroid therapy is held for the best treatment:
2. Indications where corticosteroid therapy is one of the usual treatments:
- seborrheic dermatitis with the exception of the face.
Dosage DIPROSALIC 0.05% / 3% Ointment Tube of 30 g
Applications will be limited to 2 per day for one to two weeks; in maintenance treatment, a single daily application may be sufficient. An increase in the number of applications could aggravate the adverse effects without improving the therapeutic effects.
The treatment of large surfaces requires special monitoring (number of tubes used).
Stopping treatment will be done gradually by spacing the applications or by using a corticosteroid less strong or less dosage or alternating with a base without corticoid. Mode of administration:
Gently spread the ointment over the lesions and penetrate with a light massage.
- Hypersensitivity to any of the components contained in the preparation.
- Bacterial, viral, primitive and parasitic fungal infections, even if they have an inflammatory component.
- Ulcerated lesions.
- Acne and rosacea.
- The ointment form is not suitable for oozing lesions.
Diprosalic side effects
- In case of long-term use, especially corticosteroids with a strong activity are to be feared: cutaneous atrophy, telangiectasia (especially to be feared on the face), stretch marks (at the roots of the limbs especially and occurring more readily in adolescents), ecchymotic purpura secondary to atrophy, cutaneous fragility.
- In the face, corticosteroids can create peri-oral dermatitis or create or aggravate rosacea (see warnings and contraindications).
- Can be observed delayed healing of sluggish wounds, pressure ulcers and leg ulcers (see contraindications).
- Possibility of systemic effects related to corticosteroid and / or salicylic acid (see warnings: cushingoid syndrome, slowing of growth, acute adrenal insufficiency, salicylate intoxication).
- have been reported: acneiform or pustular eruptions, hypertrichosis, depigmentation.